CURRENT PRINT ISSUE
Volume 8 Issue 2
Subscriber Services>>
Welcome, Guest
Log in
Advanced search
Diabetes and Metabolism
Type 1 diabetes
Type 2 diabetes
Gestational diabetes
Hyperglycemia and hypoglycemia
Glycemic control
Diabetic therapeutic agents
Obesity and bariatric surgery
Cross-cultural care
Diabetic comorbidities
Patient management
Pediatric Endocrinology
Type 1 diabetes
Hyperglycemia and hypoglycemia
Growth hormone therapy
Diabetic therapeutic agents
Obesity
Cross-cultural care
Diabetic comorbidities
Gender identity disorders
Thyroid
Thyroid cancer
Thyroid-stimulating hormone
Hypothyroidism
Hyperthyroidism
Thyroid nodules
Parathyroid
Thyrogenous scanning
Cardiometabolic Disorders
Cardiovascular disease
Hypertension and hypotension
Metabolic syndrome
Myocardial infarction
Atherosclerosis
Hyperlipidemia
Stroke
Coronary heart disease
Hormone Therapy
Hormone replacement therapy
Estrogen therapy
Testosterone therapy
Growth hormone therapy
Anabolic steroid abuse
Gender identity disorders
Menopause
Bone and Mineral Metabolism
Osteoporosis and fractures
Osteonecrosis of the jaw
Bone mineral density
Calcium and vitamin D supplementation
Neuroendocrinology
Idiopathic short stature
Pituitary
IGF-I levels
Adrenal
HPA axis
Noncongenital adrenal hyperplasia
Congenital adrenal hyperplasia
Pheochromocytoma
Reproduction and Androgen Disorders
PCOS
Hyperandrogenism
Androgen deficiency
Menopause
Cross-cultural care
Features
Meeting Highlights
In the Journals
Meet the Editorial Board
Resource Center:
Type 2 Diabetes
HbA1c assay for type 2 diabetes: use and considerations
In its annual update to the Standards of Care, the American Diabetes Association (ADA) endorsed the HbA1c assay as one of four recommended diagnostic tests to diagnose and screen for diabetes.
Click here
Emerging Clinical Paradigms: Exploring the Relationship between Idiopathic Short Stature and Growth Hormone
Endocrine Today video uploaded on 1/20/2010 10:23:00 AM